Whalestream has ceased operations permanently

Healthcare Sector

NVO

Market Tracker

$48.86
-0.03
(-0.06%)
8:00 pm
Next Earnings: (est.) n/a
  • NVO (Selected)

    Novo Nordisk A/S
  • NVOS

    Novo Integrated Sciences, Inc.
  • NVOX

NVO Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

NVO Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

NVO Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

NVO Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

NVO Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

NVO Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
08/21/2026 PUT $35.00 5,779 +1,204 +26.32%
07/02/2026 CALL $49.50 1,650 +1,087 +193.07%
09/18/2026 PUT $40.00 24,612 +764 +3.20%
12/17/2027 CALL $90.00 2,688 +735 +37.63%
07/02/2026 CALL $49.00 1,705 +636 +59.49%
12/17/2027 CALL $70.00 7,109 +580 +8.88%
07/02/2026 PUT $44.00 3,519 -92 -2.55%
01/21/2028 PUT $50.00 3,257 -109 -3.24%
09/18/2026 CALL $45.00 12,696 -238 -1.84%
07/02/2026 PUT $52.00 22 -283 -92.79%
12/18/2026 CALL $70.00 1,916 -296 -13.38%
07/02/2026 CALL $48.00 4,742 -319 -6.30%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

NVO Major Holders

Name Pct Held Shares Total
Harbor Capital Appreciation Fund 0.18% 3.11M 481.53M
Washington Mutual Investors Fund 0.09% 1.51M 234.45M
Vanguard U.S. Growth Fund 0.07% 1.27M 196.47M
Loomis Sayles Growth Fund 0.07% 1.18M 183.13M
Fidelity Blue Chip Growth Fund 0.07% 1.13M 175.35M
Amana Mutual Funds Trust-Growth Fund 0.06% 1M 155.09M
PGIM Jennison Growth Fd 0.05% 828.11k 128.15M
Blackrock Equity Dividend Fund 0.04% 712k 110.18M
New Perspective Fund Inc 0.04% 691.44k 107M
Price (T.Rowe) International Stock Fund 0.04% 674k 104.3M

NVO News

  • Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?

    07/08 05:21 pm

    The Motley Fool

    Read more
  • Is It Too Late to Buy Eli Lilly?

    07/08 02:10 pm

    The Motley Fool

    Read more
  • Prediction: Eli Lilly Stock Will Hit This Price by the End of 2026

    07/08 08:30 am

    The Motley Fool

    Read more
  • Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom

    07/07 05:30 pm

    The Motley Fool

    Read more
  • Hims & Hers Pullback Could Create a Better Entry Into GLP-1 Demand

    07/07 11:37 am

    Investing.com

    Read more
  • Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.

    07/07 08:10 am

    The Motley Fool

    Read more
  • Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?

    07/06 01:09 pm

    The Motley Fool

    Read more
  • Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?

    07/06 07:15 am

    The Motley Fool

    Read more
  • How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030?

    07/05 01:05 am

    The Motley Fool

    Read more
  • Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are Saying

    07/04 05:10 am

    The Motley Fool

    Read more
  • Johnson & Johnson Is Walking Away From a $100 Billion Obesity Market. Could That Actually Make It the Better Long-Term Buy Than Eli Lilly?

    07/03 09:15 pm

    The Motley Fool

    Read more
  • Here's Why Viking Therapeutics Stock Surged Higher in June

    07/03 09:25 am

    The Motley Fool

    Read more
  • Big Pharma Has a Case of Merger Mania

    06/30 12:26 am

    The Motley Fool

    Read more
  • Is Septerna a Stock to Sell After an Insider Let Go of 15,000 Shares?

    06/29 11:05 pm

    The Motley Fool

    Read more
  • 2 Top Growth Stocks to Buy Right Now Without Hesitation

    06/29 05:10 am

    The Motley Fool

    Read more
  • Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

    06/27 03:15 pm

    The Motley Fool

    Read more
  • Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?

    06/26 08:15 pm

    The Motley Fool

    Read more
  • Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

    06/26 11:05 am

    The Motley Fool

    Read more
  • An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?

    06/25 11:18 am

    The Motley Fool

    Read more
  • Zealthy Expands Insurance Coordination for GLP-1 Weight-Loss Medications

    06/23 04:52 pm

    GlobeNewswire Inc.

    Read more
  • Novo Nordisk A/S - share repurchase programme

    06/22 08:51 am

    GlobeNewswire Inc.

    Read more
  • TheDoseReport Announces Which GLP-1 is Best? Semaglutide and Tirzepatide

    06/21 07:33 am

    GlobeNewswire Inc.

    Read more
  • Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026?

    06/20 11:02 am

    The Motley Fool

    Read more
  • 3 Under-the-Radar Stocks to Buy and Hold for a Decade

    06/16 03:30 am

    The Motley Fool

    Read more
  • Novo Nordisk’s Wegovy Pill Turns Pricing Pain Into a Volume Bet

    06/15 02:07 pm

    Investing.com

    Read more
  • 3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow

    06/14 08:15 am

    The Motley Fool

    Read more
  • Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

    06/12 12:32 pm

    The Motley Fool

    Read more
  • Is Viking Therapeutics Stock Going to $100?

    06/12 01:15 am

    The Motley Fool

    Read more
  • Novo Nordisk Advances Weight-Loss Portfolio With UK Approval Of Wegovy Tablet

    06/11 01:34 pm

    Benzinga

    Read more
  • iShares U.S. Pharmaceuticals ETF Tops Simplify Health Care ETF Returns

    06/10 02:17 pm

    The Motley Fool

    Read more
  • Why 1 Wall Street Analyst Thinks Viking Therapeutics Stock Could Soar 188%

    06/10 01:27 pm

    The Motley Fool

    Read more
  • Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery

    06/10 02:35 am

    GlobeNewswire Inc.

    Read more
  • A Weight-Loss Rival Just Crashed 23%. Why That's Great News for Eli Lilly and Novo Nordisk.

    06/08 12:14 pm

    The Motley Fool

    Read more
  • Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs

    06/08 08:55 am

    Benzinga

    Read more
  • Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?

    06/06 09:15 am

    The Motley Fool

    Read more
  • Eli Lilly Sees More Dealmaking Ahead as Management Looks To Leverage Its GLP-1 Success

    06/04 09:27 am

    The Motley Fool

    Read more
  • Lilly's New Drug Just Delivered the Largest Weight Loss Ever Seen in a Clinical Trial -- Here's What It Means for Investors

    05/30 08:15 am

    The Motley Fool

    Read more
  • The Smartest Growth Stocks to Buy With $2,000 Right Now

    05/30 06:15 am

    The Motley Fool

    Read more
  • Contrarian Opinion: Novo Nordisk Is A Better Buy Than Eli Lilly Right Now

    05/28 12:15 pm

    The Motley Fool

    Read more
  • President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?

    05/27 02:02 pm

    The Motley Fool

    Read more
  • Prediction: These 2 Obesity Drug Stocks Could Double in 2026

    05/26 04:04 am

    The Motley Fool

    Read more
  • Eli Lilly Just Got a Huge Vote of Confidence From Morgan Stanley -- and It's All About Mounjaro

    05/25 07:15 pm

    The Motley Fool

    Read more
  • Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know.

    05/25 05:05 am

    The Motley Fool

    Read more
  • Is Viking Therapeutics a Top Takeover Target?

    05/23 04:31 pm

    The Motley Fool

    Read more
  • The Most Important Healthcare Stock You're Not Watching

    05/22 05:15 pm

    The Motley Fool

    Read more
  • Novo Nordisk A/S: CHMP recommends EU approval of Wegovy® 7.2 mg in a single-dose pen, providing up to 20.7% mean weight loss (1)

    05/22 01:30 pm

    GlobeNewswire Inc.

    Read more
  • From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook

    05/21 10:43 am

    Investing.com

    Read more
  • Best Weight Loss Drug Stocks to Buy in 2026

    05/20 11:15 pm

    The Motley Fool

    Read more

🎁

Take 50% OFF With Code: